|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.6 SEK | -4.74% |
|
-8.37% | -10.58% |
| 08:00am | Vitrolife AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 18 | Memphasys Secures Additional Order for Fertility Device System in Japan; Shares Jump 9% | MT |
Vitrolife AB (publ) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 3,234 million compared to SEK 1,681 million a year ago. Net income was SEK 394 million compared to SEK 341 million a year ago.
Basic earnings per share from continuing operations was SEK 2.91 compared to SEK 2.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.58% | 2.25B | |
| -0.84% | 12.58B | |
| -19.65% | 6.82B | |
| -2.45% | 5.14B | |
| -7.82% | 4.22B | |
| -0.84% | 4.21B | |
| -47.89% | 3.47B | |
| +8.57% | 2.65B | |
| -2.61% | 1.69B | |
| -12.09% | 1.48B |
VITROLIFE AB 
